Sources sought
High Performance Antigen Diagnostics
RRPV-HPAD
Office of Assistant Secretary for Preparedness and Response, Aspr Barda Div Contracts MGMT & Acq. Research and Development in Biotechnology (except Nanobiotechnology).
Response deadline
July 17, 2026 at 1:00 PM EDT
Closed 107 days ago. Posted June 17, 2026. Scheduled to archive August 1, 2026.
Get the next one like this from Office of Assistant Secretary for Preparedness and Response by email, the day it is posted.Find my opportunities
This one closed in 2026
18 like it are open now in research and development in biotechnology (except nanobiotechnology)
- Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
Office of Assistant Secretary for Preparedness and Response, Barda - Aspr / Daappo / Barda DCMA
SolicitationNAICS 541714Washington, DC75A50126R00001_RFP_NPIVS_27Closes in 19 daysNov 20 - ARPA-H Emerging Health Innovators (EHI) Initiative
National Institutes of Health, Advanced Research Projects Agency for Health (Arpa-H)
SolicitationNAICS 541714District of ColumbiaARPA-H-SOL-26-150Closes in 101 daysFeb 10, 2027 - BROAD AGENCY ANNOUNCEMENT - BIOMEDICAL RESEARCH AND DIVING EQUIPMENT DEVELOPMENT
Department of the Navy, NAVSEA HQ
SolicitationNAICS 541714District of ColumbiaN0002427S0001Closes in 394 daysNov 30, 2027
All 18 open in research and development in biotechnology (except nanobiotechnology)
Description
As published on SAM.gov.
“High Performance Antigen Diagnostics” Request for Information (RFI) Purpose The Rapid Response Partnership Vehicle (RRPV) is issuing this Request for Information (RFI) to better understand the research, development, and product landscape of current and next-generation high performance immunoassay technologies suitable for antigen testing in near-patient settings. While conventional antigen-based immunoassays offer speed, ease of use, and low cost, they remain limited by lower analytical sensitivity and limited multiplexing capability compared to nucleic acid amplification tests (NAATs), limiting their clinical utility, particularly for early infections and syndromic panels.
Attachments
Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.
- RFI RRPV HIPE.pdf2.0 MB, June 17, 2026
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
June 17, 2026
Sources sought
Due July 17, 2026 at 1:00 PM EDT. SAM.gov, notice 04b319ce28e94b63af8f8fa7095615ae
1 revisions on SAM
- June 17, 2026: publish, sources sought
Points of contact
- ATIrrpv@ati.org